Human CD4+ memory T-lymphocyte responses to SARS coronavirus infection

Virology

Volumn 368, Issue 2, 2007, Pages 317-321

  Libraty, Daniel H ^a   O'Neil, Kimberly M ^a   Baker, Lauren M ^a   Acosta, Luz P ^b   Olveda, Remigio M ^b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b RESEARCH INSTITUTE FOR TROPICAL MEDICINE   (Philippines)

Author keywords

CD4+ T cell; Coronavirus; Immunity; SARS

Indexed keywords

IMMUNOGLOBULIN G; VIRUS PROTEIN; VITRONECTIN;

ARTICLE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; HLA SYSTEM; HUMAN; IMMUNE RESPONSE; PRIORITY JOURNAL; PROTEIN STRUCTURE; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME;

AMINO ACID SEQUENCE; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; CONVALESCENCE; HUMANS; IMMUNOLOGIC MEMORY; INTERFERON TYPE II; PEPTIDES; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; VIRAL STRUCTURAL PROTEINS;

CORONAVIRUS; SARS CORONAVIRUS;

EID: 35648940787     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2007.07.015     Document Type: Article

References (19)

1. (2003). SARS outbreak in the Philippines. Wkly. Epidemiol. Rec. 78 (22), 189-92.
2. (2006). "SARS: how a global epidemic was stopped." World Health Organization, Western Pacific Region. WHO Press, Geneva Switzerland.
3. Drosten C., Gunther S., Preiser W., van der Werf S., Brodt H.R., Becker S., Rabenau H., Panning M., Kolesnikova L., Fouchier R.A., Berger A., Burguiere A.M., Cinatl J., Eickmann M., Escriou N., Grywna K., Kramme S., Manuguerra J.C., Muller S., Rickerts V., Sturmer M., Vieth S., Klenk H.D., Osterhaus A.D., Schmitz H., and Doerr H.W. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N. Engl. J. Med. 348 20 (2003) 1967-1976
4. Greenough T.C., Babcock G.J., Roberts A., Hernandez H.J., Thomas Jr. W.D., Coccia J.A., Graziano R.F., Srinivasan M., Lowy I., Finberg R.W., Subbarao K., Vogel L., Somasundaran M., Luzuriaga K., Sullivan J.L., and Ambrosino D.M. Development and characterization of a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody that provides effective immunoprophylaxis in mice. J. Infect. Dis. 191 4 (2005) 507-514
5. He Y., Lu H., Siddiqui P., Zhou Y., and Jiang S. Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies. J. Immunol. 174 8 (2005) 4908-4915
6. Hwang W.C., Lin Y., Santelli E., Sui J., Jaroszewski L., Stec B., Farzan M., Marasco W.A., and Liddington R.C. Structural basis of neutralization by a human anti-severe acute respiratory syndrome spike protein antibody, 80R. J. Biol. Chem. 281 45 (2006) 34610-34616
7. Jameson J., Cruz J., and Ennis F.A. Human cytotoxic T-lymphocyte repertoire to influenza A viruses. J. Virol. 72 11 (1998) 8682-8689
8. Ksiazek T.G., Erdman D., Goldsmith C.S., Zaki S.R., Peret T., Emery S., Tong S., Urbani C., Comer J.A., Lim W., Rollin P.E., Dowell S.F., Ling A.E., Humphrey C.D., Shieh W.J., Guarner J., Paddock C.D., Rota P., Fields B., DeRisi J., Yang J.Y., Cox N., Hughes J.M., LeDuc J.W., Bellini W.J., and Anderson L.J. A novel coronavirus associated with severe acute respiratory syndrome. N. Engl. J. Med. 348 20 (2003) 1953-1966
9. Li F., Li W., Farzan M., and Harrison S.C. Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science 309 5742 (2005) 1864-1868
10. Linnemann T., Jung G., and Walden P. Detection and quantification of CD4(+) T cells with specificity for a new major histocompatibility complex class II-restricted influenza A virus matrix protein epitope in peripheral blood of influenza patients. J. Virol. 74 18 (2000) 8740-8743
11. Mack S.J., Bugawan T.L., Moonsamy P.V., Erlich J.A., Trachtenberg E.A., Paik Y.K., Begovich A.B., Saha N., Beck H.P., Stoneking M., and Erlich H.A. Evolution of Pacific/Asian populations inferred from HLA class II allele frequency distributions. Tissue Antigens 55 5 (2000) 383-400
12. + T cells by intracellular cytokine staining. J. Immunol. Methods 284 1-2 (2004) 89-97
13. Peng H., Yang L.T., Li J., Lu Z.Q., Wang L.Y., Koup R.A., Bailer R.T., and Wu C.Y. Human memory T cell responses to SARS-CoV E protein. Microbes Infect. 8 9-10 (2006) 2424-2431
14. Peng H., Yang L.T., Wang L.Y., Li J., Huang J., Lu Z.Q., Koup R.A., Bailer R.T., and Wu C.Y. Long-lived memory T lymphocyte responses against SARS coronavirus nucleocapsid protein in SARS-recovered patients. Virology 351 2 (2006) 466-475
15. Rammensee H., Bachmann J., Emmerich N.P., Bachor O.A., and Stevanovic S. SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 50 3-4 (1999) 213-219
16. Roberts A., Thomas W.D., Guarner J., Lamirande E.W., Babcock G.J., Greenough T.C., Vogel L., Hayes N., Sullivan J.L., Zaki S., Subbarao K., and Ambrosino D.M. Therapy with a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody reduces disease severity and viral burden in golden Syrian hamsters. J. Infect. Dis. 193 5 (2006) 685-692
17. Singh H., and Raghava G.P. ProPred: prediction of HLA-DR binding sites. Bioinformatics 17 12 (2001) 1236-1237
18. Subbarao K., McAuliffe J., Vogel L., Fahle G., Fischer S., Tatti K., Packard M., Shieh W.J., Zaki S., and Murphy B. Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice. J. Virol. 78 7 (2004) 3572-3577
19. Yang L.T., Peng H., Zhu Z.L., Li G., Huang Z.T., Zhao Z.X., Koup R.A., Bailer R.T., and Wu C.Y. Long-lived effector/central memory T-cell responses to severe acute respiratory syndrome coronavirus (SARS-CoV) S antigen in recovered SARS patients. Clin. Immunol. 120 2 (2006) 171-178